The role of MRI in pharmacovigilance of natalizumab-treated MS patients: a “known unknown”?

M.P. Wattjes

    Research output: PhD ThesisPhD Thesis - Research VU Amsterdam, graduation VU Amsterdam

    102 Downloads (Pure)
    Original languageEnglish
    QualificationPhD
    Awarding Institution
    • Vrije Universiteit Amsterdam
    Supervisors/Advisors
    • Barkhof, F., Supervisor, External person
    • Uitdehaag, B.M.J., Supervisor, External person
    • Killestein, J., Co-supervisor, External person
    Award date3 Jun 2019
    Print ISBNs9783940117212
    Publication statusPublished - 2019

    Keywords

    • MRI
    • Multiple sclerosis
    • natalizumab
    • pharmacovigilance

    Cite this